Trial Outcomes & Findings for Anaesthesia for Laparoscopic Sleeve Gastrectomy (NCT NCT03029715)

Results Overview

Total paracetamol consumption.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

100 participants

Primary outcome timeframe

Within one hour after surgery

Results posted on

2020-09-16

Participant Flow

Participant milestones

Participant milestones
Measure	Intravenous Anaesthesia Propofol Dexmedetomidine Remifentanil Propofol: Total intravenous anaesthesia. Remifentanil: Narcotics Dexmedetomidine: Total intravenous anaesthesia	Inhalation Anaesthesia Desflurane Remifentanil Remifentanil: Narcotics Desflurane: Inhalation anaesthesia.
Overall Study STARTED	50	50
Overall Study COMPLETED	50	50
Overall Study NOT COMPLETED	0	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Anaesthesia for Laparoscopic Sleeve Gastrectomy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Intravenous Anaesthesia n=50 Participants Propofol Dexmedetomidine Remifentanil Propofol: Total intravenous anaesthesia. Remifentanil: Narcotics Dexmedetomidine: Total intravenous anaesthesia	Inhalation Anaesthesia n=50 Participants Desflurane Remifentanil Remifentanil: Narcotics Desflurane: Inhalation anaesthesia.	Total n=100 Participants Total of all reporting groups
Age, Continuous	35.31 years STANDARD_DEVIATION 10.43 • n=93 Participants	34.35 years STANDARD_DEVIATION 11.15 • n=4 Participants	34.83 years STANDARD_DEVIATION 10.79 • n=27 Participants
Sex: Female, Male Female	35 Participants n=93 Participants	33 Participants n=4 Participants	68 Participants n=27 Participants
Sex: Female, Male Male	15 Participants n=93 Participants	17 Participants n=4 Participants	32 Participants n=27 Participants
Region of Enrollment Egypt	50 Participants n=93 Participants	50 Participants n=4 Participants	100 Participants n=27 Participants

PRIMARY outcome

Timeframe: Within one hour after surgery

Total paracetamol consumption.

Outcome measures

Outcome measures
Measure	Sleeve Gastrectomy 1 n=50 Participants Propofol Dexmedetomidine Remifentanil Propofol: Total intravenous anaesthesia. Remifentanil: Narcotics Dexmedetomidine: Total intravenous anaesthesia	Sleeve Gastrectomy 2 n=50 Participants Desflurane Remifentanil Remifentanil: Narcotics Desflurane: Inhalation anaesthesia.
Analgesic Requirements.	3.56 mg Standard Deviation 1.01	1.67 mg Standard Deviation 1.03

SECONDARY outcome

Timeframe: During operation and follow-up, an average of 2 hours

Outcome measures

Outcome measures
Measure	Sleeve Gastrectomy 1 n=50 Participants Propofol Dexmedetomidine Remifentanil Propofol: Total intravenous anaesthesia. Remifentanil: Narcotics Dexmedetomidine: Total intravenous anaesthesia	Sleeve Gastrectomy 2 n=50 Participants Desflurane Remifentanil Remifentanil: Narcotics Desflurane: Inhalation anaesthesia.
The Intra-operative Mean Arterial Blood Pressure.	71.05 mmHg Standard Deviation 3.06	62.7 mmHg Standard Deviation 2.98

Adverse Events

Intravenous Anaesthesia

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Inhalation Anaesthesia

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Ezzeldin Ibrahim

Menoufia Univeristy

Phone: 0021006303178

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place